Global tuberculosis report 2022
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional
Tuberculosis (TB)
-
Drug-resistant TB threatens to kill 75 million people by 2050, cost $16.7 trillion
Over the next 35 years, multidrug-resistant tuberculosis will kill 75 million people and could cost the global economy a cumulative $16.7 trillion (£15 trillion) - the equivalent of the European Union’s
-
10,000 new TB cases diagnosed in Tamil Nadu
As many as 10,000 persons were diagnosed with tuberculosis (TB) by private practitioners in the last one year in Tamil Nadu. The largest concentration of such persons was in northern and central regions
-
Sub Saharan Africans enrolled in phase 3 clinical trial of new promising TB drug
A global phase 3 clinical trial named STAND (Shortening Treatment by Advancing Novel Drugs) in patients who are currently considered to have either drug-sensitive or multidrug-resistant TB has been launched
-
Tuberculosis and superbug strains "ravaging" Europe, WHO warns
As many as 1,000 people a day in Europe contract tuberculosis, and slow progress against the disease coupled with rising drug resistance mean the region is unlikely to defeat it until next century, health
-
First survey on TB in weavers begins in Varanasi; 50 Teams To Cover 25,000 Weaver Households
The golden motifs and shimmering silk often eclipses the perennial risk of tuberculosis Varanasi silk weavers live with. Though considered highly vulnerable to TB, health officials do not have a clear
-
Most MDR TB patients in Mumbai are under 35: Study
A medical study conducted in Mumbai and its satellite towns of Navi Mumbai and Thane showed that youngsters formed the bulk of patients suffering from multi-drug resistant tuberculosis (MDR TB). This finding
-
Govt embarks on largest ever survey of spurious, sub-standard drugs
3 types of drugs to be tested Amid concerns around the quality of medicines being manufactured in India for domestic use and export, the government has embarked on the largest ever survey of spurious
-
Britain, Europe’s TB hub, seeks to wipe out the disease
Health authorities launched an 11.5 million pounds ($17.4 million) plan on Monday to tackle Britain’s persistent tuberculosis problem, seeking to eradicate the contagious lung disease. Britain has one
-
1st in 50 years: Nod for new Tuberculosis drug
Bedaquiline is in use in US and EU against multi-drug-resistant strains With cases of Multi-Drug Resistant-Tuberculosis (MDR-TB) and extensively drug resistant TB (XDR TB) threatening the country, Bedaquiline
-
Pakistan State of Environment Report: The Monthly Overview, November, 2014
<p><strong>The Khyber Pakhtunkhwa cabinet in Pakistan, decided to lift the over two decades long ban on forest harvesting besides managing forests along scientific lines in line with a working plan made by the government. Read more in November 2014 edition of the Monthly Overview on State of Environment, Pakistan</strong></p>